AIM ImmunoTech Inc
ASE:AIM
| Market Cap (Intraday) | 99.61M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.04 |
| 50-Day MA | $2.19 |
| 200-Day MA | $2.17 |
AIM ImmunoTech Inc Stock, ASE:AIM
2117 South West Highway 484, 2117 SW Highway 484, Ocala, Florida 34473
United States of America
Phone: +1.352.448.7797
Number of Employees: 23
Description
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.